PLx Pharma Inc. Common Stock
PLXP
PLXP was delisted on the 12th of April, 2023.
14 hedge funds and large institutions have $3.24M invested in PLx Pharma Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 4 closing their positions.
0.56% less ownership
Funds ownership: 24.83% → 24.27% (-0.56%)
12% less capital inflows, than outflows
Capital inflows: $1.43M | Capital outflows: $1.62M
22% less funds holding
Funds holding: 18 → 14 (-4)
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Park West Asset Management
San Francisco,
California
|
+$1.42M |
| 2 |
Renaissance Technologies
New York
|
+$7.13K |
| 3 |
BlackRock
New York
|
+$1.14K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
|
-$1.07M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$242K |
| 3 |
Millennium Management
New York
|
-$103K |
| 4 |
CVI Holdings
Wilmington,
Delaware
|
-$56K |
| 5 |
Goldman Sachs
New York
|
-$50.9K |
PLXP Hedge Fund Activity: Q4 2018 in Review
14 of the 4,506 institutional investors tracked by Wall St. Rank reported a position in PLx Pharma Inc. Common Stock (PLXP) for Q4 2018, worth a combined $3.24M — down 63% from $8.79M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of PLXP and 0 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 3 added.
The largest buyer was Park West Asset Management, adding an estimated $1.42M. The largest seller was Harel Insurance Investments & Financial Services, cutting an estimated $1.07M.
- 14 institutional investors held PLx Pharma Inc. Common Stock (PLXP) as of Q4 2018, down from 18 in Q3 2018.
- Funds reported $3.24M of PLx Pharma Inc. Common Stock stock for Q4 2018, down 63% quarter-over-quarter.
- 0 funds opened new PLx Pharma Inc. Common Stock positions in Q4 2018 and 4 closed out, a net change of -4 holders.
- The largest PLx Pharma Inc. Common Stock buyer in Q4 2018 was Park West Asset Management, an estimated $1.42M added.
- The largest PLx Pharma Inc. Common Stock seller in Q4 2018 was Harel Insurance Investments & Financial Services, an estimated $1.07M sold.
Based on aggregated 13F filings for Q4 2018.